Medical Device Development for Children and Young People—Reviewing the Challenges and Opportunities

Paul Dimitri; Valeria Pignataro; Mariangela Lupo; Donato Bonifazi; Maria Henke; Umberto Musazzi; Floris Ernst; Paola Minghetti; Davide Redaelli; Sophia Antimisiaris; Giovanni Migliaccio; Fedele Bonifazi; Luca Marciani; Aaron Courtenay; Nunzio Denora; Angela Lopedota

doi:10.3390/pharmaceutics13122178

Medical Device Development for Children and Young People—Reviewing the Challenges and Opportunities

Paul Dimitri, Valeria Pignataro, Mariangela Lupo, Donato Bonifazi, Maria Henke, Umberto Musazzi, Floris Ernst, Paola Minghetti, Davide Redaelli, Sophia Antimisiaris, Giovanni Migliaccio, Fedele Bonifazi, Luca Marciani, Aaron Courtenay, Nunzio Denora, Angela Lopedota

Research output: Contribution to journal › Review article › peer-review

7 Citations (Scopus)

16 Downloads (Pure)

Abstract

Development of specific medical devices (MDs) is required to meet the healthcare needs of children and young people (CYP). In this context, MD development should address changes in growth and psychosocial maturation, physiology, and pathophysiology, and avoid inappropriate repurposing of adult technologies. Underpinning the development of MD for CYP is the need to ensure MD safety and effectiveness through pediatric MD-specific regulations. Contrary to current perceptions of limited market potential, the global pediatric healthcare market is expected to generate around USD 15,984 million by 2025. There are 1.8 billion young people in the world today; 40% of the global population is under 24, creating significant future healthcare market opportunities. This review highlights a number of technology areas that have led to successful pediatric MD, including 3D printing, advanced materials, drug delivery, and diagnostic imaging. To ensure the targeted development of MD for CYP, collaboration across multiple professional disciplines is required, facilitated by a platform to foster collaboration and drive innovation. The European Pediatric Translational Research Infrastructure (EPTRI) will be established as the European platform to support collaboration, including the life sciences industrial sector, to identify unmet needs in child health and support the development, adoption, and commercialization of pediatric MDs

Original language	English
Article number	2178
Pages (from-to)	1-17
Number of pages	17
Journal	Pharmaceutics
Volume	13
Issue number	12
DOIs	https://doi.org/10.3390/pharmaceutics13122178
Publication status	Published (in print/issue) - 17 Dec 2021

Bibliographical note

Funding Information:
Acknowledgments: We acknowledge the European Pediatric Translational Research Infrastructure (EPTRI project) funded by the European Union’s Horizon 2020 program under grant agreement no. 777554.

Funding Information:
Funding: This work is partially funded by the National Institute for Health Research (NIHR) MedTech and In-vitro Diagnostic Cooperative Programme (NIHR Children and Young People MedTech Cooperative). The views expressed are those of the author and not necessarily those of the NIHR or the Department of Health and Social Care.

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.

Keywords

medical devices
pediatrics
3D printing
diagnostic imaging
delivery device
patient involvement

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3390/pharmaceutics13122178Licence: CC BY

pharmaceutics-13-02178Final published version, 1.17 MBLicence: CC BY

Cite this

Dimitri, P., Pignataro, V., Lupo, M., Bonifazi, D., Henke, M., Musazzi, U., Ernst, F., Minghetti, P., Redaelli, D., Antimisiaris, S., Migliaccio, G., Bonifazi, F., Marciani, L., Courtenay, A., Denora, N., & Lopedota, A. (2021). Medical Device Development for Children and Young People—Reviewing the Challenges and Opportunities. Pharmaceutics, 13(12), 1-17. Article 2178. https://doi.org/10.3390/pharmaceutics13122178

@article{c05c532833464991917e9b9105c0fd4b,

title = "Medical Device Development for Children and Young People—Reviewing the Challenges and Opportunities",

abstract = "Development of specific medical devices (MDs) is required to meet the healthcare needs of children and young people (CYP). In this context, MD development should address changes in growth and psychosocial maturation, physiology, and pathophysiology, and avoid inappropriate repurposing of adult technologies. Underpinning the development of MD for CYP is the need to ensure MD safety and effectiveness through pediatric MD-specific regulations. Contrary to current perceptions of limited market potential, the global pediatric healthcare market is expected to generate around USD 15,984 million by 2025. There are 1.8 billion young people in the world today; 40% of the global population is under 24, creating significant future healthcare market opportunities. This review highlights a number of technology areas that have led to successful pediatric MD, including 3D printing, advanced materials, drug delivery, and diagnostic imaging. To ensure the targeted development of MD for CYP, collaboration across multiple professional disciplines is required, facilitated by a platform to foster collaboration and drive innovation. The European Pediatric Translational Research Infrastructure (EPTRI) will be established as the European platform to support collaboration, including the life sciences industrial sector, to identify unmet needs in child health and support the development, adoption, and commercialization of pediatric MDs",

keywords = "medical devices, pediatrics, 3D printing, diagnostic imaging, delivery device, patient involvement",

author = "Paul Dimitri and Valeria Pignataro and Mariangela Lupo and Donato Bonifazi and Maria Henke and Umberto Musazzi and Floris Ernst and Paola Minghetti and Davide Redaelli and Sophia Antimisiaris and Giovanni Migliaccio and Fedele Bonifazi and Luca Marciani and Aaron Courtenay and Nunzio Denora and Angela Lopedota",

note = "Funding Information: Acknowledgments: We acknowledge the European Pediatric Translational Research Infrastructure (EPTRI project) funded by the European Union{\textquoteright}s Horizon 2020 program under grant agreement no. 777554. Funding Information: Funding: This work is partially funded by the National Institute for Health Research (NIHR) MedTech and In-vitro Diagnostic Cooperative Programme (NIHR Children and Young People MedTech Cooperative). The views expressed are those of the author and not necessarily those of the NIHR or the Department of Health and Social Care. Publisher Copyright: {\textcopyright} 2021 by the authors. Licensee MDPI, Basel, Switzerland.",

year = "2021",

month = dec,

day = "17",

doi = "10.3390/pharmaceutics13122178",

language = "English",

volume = "13",

pages = "1--17",

journal = "Pharmaceutics",

issn = "1999-4923",

publisher = "MDPI",

number = "12",

}

Dimitri, P, Pignataro, V, Lupo, M, Bonifazi, D, Henke, M, Musazzi, U, Ernst, F, Minghetti, P, Redaelli, D, Antimisiaris, S, Migliaccio, G, Bonifazi, F, Marciani, L, Courtenay, A, Denora, N & Lopedota, A 2021, 'Medical Device Development for Children and Young People—Reviewing the Challenges and Opportunities', Pharmaceutics, vol. 13, no. 12, 2178, pp. 1-17. https://doi.org/10.3390/pharmaceutics13122178

TY - JOUR

T1 - Medical Device Development for Children and Young People—Reviewing the Challenges and Opportunities

AU - Dimitri, Paul

AU - Pignataro, Valeria

AU - Lupo, Mariangela

AU - Bonifazi, Donato

AU - Henke, Maria

AU - Musazzi, Umberto

AU - Ernst, Floris

AU - Minghetti, Paola

AU - Redaelli, Davide

AU - Antimisiaris, Sophia

AU - Migliaccio, Giovanni

AU - Bonifazi, Fedele

AU - Marciani, Luca

AU - Courtenay, Aaron

AU - Denora, Nunzio

AU - Lopedota, Angela

N1 - Funding Information: Acknowledgments: We acknowledge the European Pediatric Translational Research Infrastructure (EPTRI project) funded by the European Union’s Horizon 2020 program under grant agreement no. 777554. Funding Information: Funding: This work is partially funded by the National Institute for Health Research (NIHR) MedTech and In-vitro Diagnostic Cooperative Programme (NIHR Children and Young People MedTech Cooperative). The views expressed are those of the author and not necessarily those of the NIHR or the Department of Health and Social Care. Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.

PY - 2021/12/17

Y1 - 2021/12/17

N2 - Development of specific medical devices (MDs) is required to meet the healthcare needs of children and young people (CYP). In this context, MD development should address changes in growth and psychosocial maturation, physiology, and pathophysiology, and avoid inappropriate repurposing of adult technologies. Underpinning the development of MD for CYP is the need to ensure MD safety and effectiveness through pediatric MD-specific regulations. Contrary to current perceptions of limited market potential, the global pediatric healthcare market is expected to generate around USD 15,984 million by 2025. There are 1.8 billion young people in the world today; 40% of the global population is under 24, creating significant future healthcare market opportunities. This review highlights a number of technology areas that have led to successful pediatric MD, including 3D printing, advanced materials, drug delivery, and diagnostic imaging. To ensure the targeted development of MD for CYP, collaboration across multiple professional disciplines is required, facilitated by a platform to foster collaboration and drive innovation. The European Pediatric Translational Research Infrastructure (EPTRI) will be established as the European platform to support collaboration, including the life sciences industrial sector, to identify unmet needs in child health and support the development, adoption, and commercialization of pediatric MDs

AB - Development of specific medical devices (MDs) is required to meet the healthcare needs of children and young people (CYP). In this context, MD development should address changes in growth and psychosocial maturation, physiology, and pathophysiology, and avoid inappropriate repurposing of adult technologies. Underpinning the development of MD for CYP is the need to ensure MD safety and effectiveness through pediatric MD-specific regulations. Contrary to current perceptions of limited market potential, the global pediatric healthcare market is expected to generate around USD 15,984 million by 2025. There are 1.8 billion young people in the world today; 40% of the global population is under 24, creating significant future healthcare market opportunities. This review highlights a number of technology areas that have led to successful pediatric MD, including 3D printing, advanced materials, drug delivery, and diagnostic imaging. To ensure the targeted development of MD for CYP, collaboration across multiple professional disciplines is required, facilitated by a platform to foster collaboration and drive innovation. The European Pediatric Translational Research Infrastructure (EPTRI) will be established as the European platform to support collaboration, including the life sciences industrial sector, to identify unmet needs in child health and support the development, adoption, and commercialization of pediatric MDs

KW - medical devices

KW - pediatrics

KW - 3D printing

KW - diagnostic imaging

KW - delivery device

KW - patient involvement

UR - https://www.mdpi.com/1999-4923/13/12/2178

UR - http://www.scopus.com/inward/record.url?scp=85121454793&partnerID=8YFLogxK

U2 - 10.3390/pharmaceutics13122178

DO - 10.3390/pharmaceutics13122178

M3 - Review article

C2 - 34959459

SN - 1999-4923

VL - 13

SP - 1

EP - 17

JO - Pharmaceutics

JF - Pharmaceutics

IS - 12

M1 - 2178

ER -

Medical Device Development for Children and Young People—Reviewing the Challenges and Opportunities

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this